TRPV4 Activation Contributes Functional Recovery from Ischemic Stroke via Angiogenesis and Neurogenesis

Molecular Neurobiology

Volumn 55, Issue 5, 2018, Pages 4127-4135

  Chen, Chun Kai ^a,b   Hsu, Po Yuan ^c   Wang, Tzu Ming ^c   Miao, Zhi Feng ^a   Lin, Ruey Tay ^a   Juo, Suh Hang H ^c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Ischemic stroke; Neurogenesis; Nitric oxide synthase; TRPV4

Indexed keywords

4ALPHA PHORBOL DIDECANOATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VASCULOTROPIN A; VASCULOTROPIN A 164A; VASCULOTROPIN A 165B; VASCULOTROPIN RECEPTOR 2; MESSENGER RNA; PHORBOL ESTER; PHORBOL-12,13-DIDECANOATE; TRPV4 PROTEIN, RAT; VANILLOID RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; CAPILLARY DENSITY; CELL MIGRATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FUNCTIONAL ASSESSMENT; IMMUNOHISTOCHEMISTRY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL MOTION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CHANNEL GATING; COMPLICATION; CONVALESCENCE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN ISCHEMIA; CELL MOVEMENT; CELL PROLIFERATION; ION CHANNEL GATING; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; NEURAL STEM CELLS; NEUROGENESIS; NITRIC OXIDE SYNTHASE TYPE III; PHORBOL ESTERS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; RNA, MESSENGER; STROKE; TRPV CATION CHANNELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 85020658488     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-017-0625-0     Document Type: Article

References (34)

1. Mozaffarian D, Benjamin EJ, Go AS et al (2016) Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:e38–e360
2. Meyer S, Verheyden G, Brinkmann N et al (2015) Functional and motor outcome 5 years after stroke is equivalent to outcome at 2 months: Follow-up of the collaborative evaluation of rehabilitation in stroke across Europe. Stroke 46:1613–1619
3. Cowman S, Royston M, Hickey A et al (2010) Stroke and nursing home care: a national survey of nursing homes. BMC Geriatr 10:4
4. Teng H, Zhang ZG, Wang L et al (2008) Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab 28:764–771
5. Zhang ZG, Chopp M (2009) Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491–500
6. Kahle MP, Bix GJ (2013) Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential. Neurorehabil Neural Repair 27:469–478
7. Everaerts W, Nilius B, Owsianik G (2010) The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol 103:2–17
8. Troidl C, Troidl K, Schierling W et al (2009) Trpv4 induces collateral vessel growth during regeneration of the arterial circulation. J Cell Mol Med 13:2613–2621
9. Zaninetti R, Fornarelli A, Ciarletta M et al (2011) Activation of TRPV4 channels reduces migration of immortalized neuroendocrine cells. J Neurochem 116:606–615
10. Hatano N, Suzuki H, Itoh Y et al (2013) TRPV4 partially participates in proliferation of human brain capillary endothelial cells. Life Sci 92:317–324
11. Randhawa PK, Jaggi AS (2015) TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection. Eur J Pharmacol 746:180–185
12. Dragoni S, Guerra G, Fiorio Pla A et al (2015) A functional transient receptor potential vanilloid 4 (TRPV4) channel is expressed in human endothelial progenitor cells. J Cell Physiol 230:95–104
13. Schmidt W, Endres M, Dimeo F et al (2013) Train the vessel, gain the brain: physical activity and vessel function and the impact on stroke prevention and outcome in cerebrovascular disease. Cerebrovasc Dis 35:303–312
14. Liu J, Wang Y, Akamatsu Y et al (2014) Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. Prog Neurobiol 115:138–156
15. Schierling W, Troidl K, Apfelbeck H et al (2011) Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel. Eur J Vasc Endovasc Surg 41:589–596
16. Wragg JW, Durant S, McGettrick HM et al (2014) Shear stress regulated gene expression and angiogenesis in vascular endothelium. Microcirculation 21:290–300
17. Zhang L, Hu X, Luo J et al (2013) Physical exercise improves functional recovery through mitigation of autophagy, attenuation of apoptosis and enhancement of neurogenesis after MCAO in rats. BMC Neurosci 14:1
18. Ke Z, Yip S, Li L et al (2011) The effects of voluntary, involuntary, and forced exercises on brain-derived neurotrophic factor and motor function recovery: a rat brain ischemia model. PLoS One 6:e16643
19. Zhu J, Song W, Li L et al (2016) Endothelial nitric oxide synthase: a potential therapeutic target for cerebrovascular diseases. Mol Brain 9:30
20. Gertz K, Endres M (2008) eNOS and stroke: prevention, treatment and recovery. Future Neurol 3:537–550
21. Gao Y, Zhao Y, Pan J et al (2014) Treadmill exercise promotes angiogenesis in the ischemic penumbra of rat brains through caveolin-1/VEGF signaling pathways. Brain Res 1585:83–90
22. Mac Gabhann F, Qutub AA, Annex BH et al (2010) Systems biology of pro-angiogenic therapies targeting the VEGF system. Wiley Interdiscip Rev Syst Biol Med 2:694–707
23. Rajagopalan S, Mohler ER, Lederman RJ et al (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108:1933–1938
24. Kikuchi R, Nakamura K, MacLauchlan S et al (2014) An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nat Med 20:1464–1471
25. Harper SJ, Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880–887
26. Sawada M, Sawamoto K (2013) Mechanisms of neurogenesis in the normal and injured adult brain. Keio J Med 62:13–28
27. Saha B, Peron S, Murray K et al (2013) Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury. Stem Cell Res 11:965–977
28. Christie KJ, Turnley AM (2013) Regulation of endogenous neural stem/progenitor cells for neural repair-factors that promote neurogenesis and gliogenesis in the normal and damaged brain. Front Cell Neurosci 6:70
29. Carreira BP, Morte MI, Inácio  et al (2010) Nitric oxide stimulates the proliferation of neural stem cells bypassing the epidermal growth factor receptor. Stem Cells 28:1219–1230
30. Zhang RL, Zhang Z, Zhang L et al (2006) Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res 83:1213–1219
31. Chen J, Zacharek A, Zhang C et al (2005) Endothelial nitric oxide synthase regulates brain derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25:2366–2375
32. Jie P, Lu Z, Hong Z et al (2016) Activation of transient receptor potential vanilloid 4 is involved in neuronal injury in middle cerebral artery occlusion in mice. Mol Neurobiol 53:8–17
33. Li L, Qu W, Zhou L et al (2013) Activation of transient receptor potential vanilloid 4 increases NMDA-activated current in hippocampal pyramidal neurons. Front Cell Neurosci 7:17
34. Navaratna D, Guo S, Arai K et al (2009) Mechanisms and targets for angiogenic therapy after stroke. Cell Adhes Migr 3:216–223